EUVIMEDEUVIMED entdecken
LeitlinieÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper

Silvia Galliazzo, Paolo Bucciarelli, Doris Barcellona iD, Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Alessandro Squizzato iD, Vincenzo Toschi, Sophie Testa, Daniela Poli

Thrombosis and Haemostasis · 01.08.2024 · 124 (08) · 803-809

DOI: 10.1055/s-0044-1782688 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2024. Verfasst von Silvia Galliazzo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Sant'Anna Hospital, ASST Lariana, Como, Italy. Hauptthemen laut MEDLINE: Vitamin K, Warfarin, Anticoagulants, International Normalized Ratio. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the era of direct oral anticoagulants, vitamin K antagonists retain a clinically relevant role in thrombotic disorders. In Italy, approximately 20% of the patients on anticoagulant therapies receives a VKA, in most cases warfarin. The optimal management of this drug is challenging and cannot disregard its intricate and unpredictable pharmacokinetic properties and patient's thrombotic and bleeding risk. Several clinical issues encountered during warfarin treatment are still unanswered and are tentatively addressed by physicians. In this regard, the Italian Federation of Centers for the diagnosis of thrombotic disorders and the Surveillance of the Antithrombotic therapies (FCSA) provides some experience-based good clinical practice's suggestions on the following topics: (1) how to start the anticoagulant treatment with warfarin and warfarin induction regimen; (2) how to manage a subtherapeutic INR value; (3) how to manage a supratherapeutic INR value in asymptomatic patients; and (4) how to manage the association of warfarin with interfering drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin KWarfarinAnticoagulantsInternational Normalized RatioThrombosisHemorrhageHumansItalyDrug MonitoringDrug InteractionsBlood CoagulationFibrinolytic Agents

Substanzen

Vitamin KWarfarinAnticoagulantsFibrinolytic Agents

Autor:innen und Institutionen

  • Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Sant'Anna Hospital, ASST Lariana, Como, Italy.
  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.
  • Thrombosis and Haemostasis Unit, University of Cagliari, Cagliari, Italy.
  • Haemostasis Center, AORN S.G. Moscati, Avellino, Italy.
  • Thrombosis and Haemostasis Unit, IRCCS, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Haemophilia and Thrombosis Center, AOU Policlinico, Bari, Italy.

ORCID-Profile: Doris Barcellona, Alessandro Squizzato

Zitieren

APA

Galliazzo, S., Bucciarelli, P., Barcellona, D., Ciampa, A., Grandone, E., Malcangi, G., Rescigno, G., Squizzato, A., Toschi, V., Testa, S., & Poli, D. (2024). Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper. Thrombosis and Haemostasis, 124(08), 803-809. https://doi.org/10.1055/s-0044-1782688

Vancouver

Galliazzo S, Bucciarelli P, Barcellona D, Ciampa A, Grandone E, Malcangi G, et al. Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper. Thrombosis and Haemostasis. 2024;124(08):803-809. doi:10.1055/s-0044-1782688

BibTeX
@article{Galliazzo2024,
  author = {Galliazzo, Silvia and Bucciarelli, Paolo and Barcellona, Doris and Ciampa, Antonio and Grandone, Elvira and Malcangi, Giuseppe and Rescigno, Giuseppe and Squizzato, Alessandro and Toschi, Vincenzo and Testa, Sophie and Poli, Daniela},
  title = {Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper},
  journal = {Thrombosis and Haemostasis},
  year = {2024},
  volume = {124},
  number = {08},
  pages = {803--809},
  doi = {10.1055/s-0044-1782688}
}
Kostenlos starten →